Cart
sales@molnova.com
CK1-IN-1
CAS No. 1784751-20-7
CK1-IN-1( PUN51207 )
Catalog No. M20134 CAS No. 1784751-20-7
CK1-IN-1 compound 1c reported in patent WO2015119579A1 is a casein kinase 1 (CK1) inhibitor. It has IC50s of 15 nM 16 nM 73 nM for CK1δ and CK1ε p38σ MAPK respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 103 | In Stock |
|
| 2MG | 56 | In Stock |
|
| 5MG | 93 | In Stock |
|
| 10MG | 155 | In Stock |
|
| 25MG | 306 | In Stock |
|
| 50MG | 461 | In Stock |
|
| 100MG | 693 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCK1-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCK1-IN-1 compound 1c reported in patent WO2015119579A1 is a casein kinase 1 (CK1) inhibitor. It has IC50s of 15 nM 16 nM 73 nM for CK1δ and CK1ε p38σ MAPK respectively.
-
DescriptionCK1-IN-1 compound 1c reported in patent WO2015119579A1 is a casein kinase 1 (CK1) inhibitor. It has IC50s of 15 nM 16 nM 73 nM for CK1δ and CK1ε p38σ MAPK respectively.
-
In Vitro——
-
In Vivo——
-
SynonymsPUN51207
-
PathwayMetabolic Enzyme/Protease
-
TargetCasein Kinase
-
RecptorCK1|p38σ MAPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1784751-20-7
-
Formula Weight383.39
-
Molecular FormulaC24H15F2N3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 60 mg/mL (156.5 mM); Water: Insoluble
-
SMILESFc1ccc(cc1)-c1nc([nH]c1-c1ccncc1)-c1ccc2ccccc2c1F
-
Chemical NamePyridine 4-[2-(1-fluoro-2-naphthalenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Filip LACOet al. 245-tri-substituted azole-based casein kinase 1 inhibitors as inducers for cardiomyogenesis. WO2015119579A1.
molnova catalog
related products
-
CK2 inhibitor 2
CK2 inhibitor 2 is a potent and selective CK2 inhibitor(IC50 = 0.66 nM) with favorable antiproliferative and antitumor activity.
-
NCC007
NCC007 is a novel CKIα and CKIδ dual inhibitors by structural modification of N9 and C2 position of longdaysin.
-
TTP 22
TTP 22 is a high affinity, ATP-competitive casein kinase 2 (CK2) inhibitor with IC50/Ki of 0.1 uM/40 nM.
